Altimmune, Inc.·4

Aug 4, 4:05 PM ET

Harris Matthew Scott 4

4 · Altimmune, Inc. · Filed Aug 4, 2025

Insider Transaction Report

Form 4
Period: 2025-07-31
Harris Matthew Scott
Chief Medical Officer
Transactions
  • Award

    Common Stock, par value $0.0001

    2025-07-31$3.14/sh+2,018$6,33716,087 total
Holdings
  • Common Stock, par value $0.0001

    (indirect: By Trust)
    67,787
Footnotes (2)
  • [F1]These shares were purchased due to participation of the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2025 through July 31, 2025.
  • [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock.

Documents

1 file
  • 4
    tm2522384-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT